{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T18:12:44Z","timestamp":1776103964092,"version":"3.50.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2020.00105","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T11:37:33Z","timestamp":1581075453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Manipulating microRNAs for the Treatment of Malignant Pleural Mesothelioma: Past, Present and Future"],"prefix":"10.3389","volume":"10","author":[{"given":"Glen","family":"Reid","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas G.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cell.2018.03.006","article-title":"Metazoan microRNAs","volume":"173","author":"Bartel","year":"2018","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","article-title":"microRNAs in cancer","volume":"60","author":"Garzon","year":"2009","journal-title":"Annu Rev Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3978\/j.issn.2072-1439","article-title":"microRNAs in mesothelioma: from tumour suppressors and biomarkers to therapeutic targets","volume":"7","author":"Reid","year":"2015","journal-title":"J Thorac Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"78193","DOI":"10.18632\/oncotarget.20409","article-title":"Targeting microRNA to improve diagnostic and therapeutic approaches for malignant mesothelioma","volume":"8","author":"Birnie","year":"2017","journal-title":"Oncotarget"},{"key":"B5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/cgt.2011.50","article-title":"EphrinA1 inhibits malignant mesothelioma tumor growth via let-7 microRNA-mediated repression of the RAS oncogene","volume":"18","author":"Khodayari","year":"2011","journal-title":"Cancer Gene Ther"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.3892\/ijo.2016.3358","article-title":"Differential microRNA expression profiling of mesothelioma and expression analysis of miR-1 and miR-214 in mesothelioma","volume":"48","author":"Amatya","year":"2016","journal-title":"Int J Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1378\/chest.12-2770","article-title":"miR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Xu","year":"2013","journal-title":"Chest"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/annonc\/mdt412","article-title":"Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma","volume":"24","author":"Reid","year":"2013","journal-title":"Ann Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jtho.2017.05.024","article-title":"Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma","volume":"12","author":"Kao","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12943-016-0529-z","article-title":"KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma","volume":"15","author":"Cheng","year":"2016","journal-title":"Mol Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/1878-0261.12386","article-title":"Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma","volume":"12","author":"He","year":"2018","journal-title":"Mol Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.molonc.2014.11.007","article-title":"MiR-score: a novel 6-microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma","volume":"9","author":"Kirschner","year":"2015","journal-title":"Mol Oncol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"17300","DOI":"10.18632\/oncotarget.24644","article-title":"MiR-21 over-expression and programmed cell death 4 down-regulation features malignant pleural mesothelioma","volume":"9","author":"Nicole","year":"2018","journal-title":"Oncotarget"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0170999","DOI":"10.1371\/journal.pone.0170999","article-title":"Identification of MiR-21-5p as a functional regulator of mesothelin expression using microRNA capture affinity coupled with next generation sequencing","volume":"12","author":"De Santi","year":"2017","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1158\/0008-5472.CAN-18-0655","article-title":"A polysome-based microRNA screen identifies miR-24-3p as a novel promigratory miRNA in mesothelioma","volume":"78","author":"Oliveto","year":"2018","journal-title":"Cancer Res"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1158\/0008-5472.CAN-09-3993","article-title":"hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma","volume":"70","author":"Pass","year":"2010","journal-title":"Cancer Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"22809","DOI":"10.1074\/jbc.M110.100354","article-title":"Pro-tumorigenic effects of miR-31 loss in mesothelioma","volume":"285","author":"Ivanov","year":"2010","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12032-014-0303-2","article-title":"Upregulation of microRNA-31 associates with a poor prognosis of malignant pleural mesothelioma with sarcomatoid component","volume":"31","author":"Matsumoto","year":"2014","journal-title":"Med Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.omtn.2017.07.001","article-title":"microRNA-31 regulates chemosensitivity in malignant pleural mesothelioma","volume":"8","author":"Moody","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1158\/0008-5472.CAN-13-2062","article-title":"Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis","volume":"74","author":"Menges","year":"2014","journal-title":"Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.18632\/oncotarget.27010","article-title":"Transcriptional suppression of the miR-15\/16 family by c-Myc in malignant pleural mesothelioma","volume":"10","author":"Williams","year":"2019","journal-title":"Oncotarget"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.3892\/or.2013.2351","article-title":"Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells","volume":"29","author":"Tanaka","year":"2013","journal-title":"Oncol Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.20517\/cdr.2019.41","article-title":"Tumour suppressor microRNAs contribute to drug resistance in malignant pleural mesothelioma by targeting anti-apoptotic pathways","volume":"2","author":"Williams","year":"2019","journal-title":"Cancer Drug Resist"},{"key":"B24","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1158\/1078-0432.CCR-10-3040","article-title":"Epigenetic silencing of microRNA-34b\/c plays an important role in the pathogenesis of malignant pleural mesothelioma","volume":"17","author":"Kubo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"23","DOI":"10.18926\/amo\/52140","article-title":"Preclinical evaluation of microRNA-34b\/c delivery for malignant pleural mesothelioma","volume":"68","author":"Ueno","year":"2014","journal-title":"Acta Med Okayama"},{"key":"B26","unstructured":"microRNA miR-34b\/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells48715\n            MakiY\n            AsanoH\n            ToyookaS\n            SohJ\n            KuboT\n            KatsuiK\n          23155254Anticancer Res322012"},{"key":"B27","doi-asserted-by":"publisher","first-page":"36338","DOI":"10.18632\/oncotarget.8916","article-title":"microRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma","volume":"7","author":"Tomasetti","year":"2016","journal-title":"Oncotarget"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1089\/ars.2013.5215","article-title":"microRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial function","volume":"21","author":"Tomasetti","year":"2014","journal-title":"Antioxidants Redox Signal"},{"key":"B29","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jtho.2017.10.016","article-title":"Dysregulated expression of the microRNA miR-137 and its target YBX1 contribute to the invasive characteristics of malignant pleural mesothelioma","volume":"13","author":"Johnson","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5319","DOI":"10.1038\/onc.2013.476","article-title":"Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma","volume":"33","author":"Cioce","year":"2014","journal-title":"Oncogene"},{"key":"B31","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3389\/fonc.2018.00446","article-title":"miR-182 and miR-183 promote cell proliferation and invasion by targeting FOXO1 in mesothelioma","volume":"8","author":"Suzuki","year":"2018","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"23480","DOI":"10.18632\/oncotarget.4346","article-title":"miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma","volume":"6","author":"Williams","year":"2015","journal-title":"Oncotarget"},{"key":"B33","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Modern Pathol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1158\/1538-7445.AM2018-523","article-title":"Abstract 523: miR-206 inhibits pleural mesothelioma by targeting an active KRAS\/CDK4\/CCND1 pathway","volume":"78","author":"Singh","year":"2018","journal-title":"Cancer Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/1541-7786.MCR-14-0442","article-title":"Loss of miR-223 and JNK signaling contribute to elevated stathmin in malignant pleural mesothelioma","volume":"13","author":"Birnie","year":"2015","journal-title":"Mol Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.ymthe.2019.05.020","article-title":"microRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis","volume":"27","author":"Singh","year":"2019","journal-title":"Mol Ther"},{"key":"B37","first-page":"1996","article-title":"microRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells","volume":"6","author":"Khodayari","year":"2016","journal-title":"Am J Cancer Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nbt.1547","article-title":"Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug","volume":"27","author":"MacDiarmid","year":"2009","journal-title":"Nat Biotechnol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.4161\/cc.6.17.4648","article-title":"Bacterially-derived nanocells for tumor-targeted delivery of chemotherapeutics and cell cycle inhibitors","volume":"6","author":"MacDiarmid","year":"2007","journal-title":"Cell Cycle"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1158\/1538-7445.AM2015-3976","article-title":"Abstract 3976: Targeted delivery of a synthetic microRNA-based mimic as an approach to cancer therapy","volume":"75","author":"Reid","year":"2015","journal-title":"Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1164\/rccm.201503-0461LE","article-title":"A significant metabolic and radiological response after a novel targeted microRNA-based treatment approach in malignant pleural mesothelioma","volume":"191","author":"Kao","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0186137","DOI":"10.1371\/journal.pone.0186137","article-title":"Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models","volume":"12","author":"Alfaleh","year":"2017","journal-title":"PLoS ONE"},{"key":"B44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10585-016-9783-0","article-title":"MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively","volume":"33","author":"Pu","year":"2016","journal-title":"Clin Exp Metastasis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/onc.2013.574","article-title":"microRNA-193a-3p and\u22125p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4\/PIK3R3\/mTOR\/S6K2 signaling pathway","volume":"34","author":"Yu","year":"2015","journal-title":"Oncogene"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-080","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"key":"B47","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B48","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1073\/pnas.0808263106","article-title":"Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor","volume":"106","author":"Segura","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B50","doi-asserted-by":"publisher","first-page":"18121","DOI":"10.1074\/jbc.M113.478560","article-title":"c-MYC-regulated miR-23a\/24-2\/27a cluster promotes mammary carcinoma cell invasion and hepatic metastasis by targeting Sprouty2","volume":"288","author":"Li","year":"2013","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/JTO.0b013e3182a0840a","article-title":"ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma","volume":"8","author":"Cheng","year":"2013","journal-title":"J Thorac Oncol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/ddr.21257","article-title":"The role of miR-21 in cancer","volume":"76","author":"Pfeffer","year":"2015","journal-title":"Drug Dev Res"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e33214","DOI":"10.1371\/journal.pone.0033214","article-title":"Inhibition of mesothelin as a novel strategy for targeting cancer cells","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS ONE"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/cdd.2013.125","article-title":"The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease","volume":"20","author":"Mogilyansky","year":"2013","journal-title":"Cell Death Differ"},{"key":"B55","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.cell.2015.07.008","article-title":"A biogenesis step upstream of microprocessor controls miR-17 approximately 92 expression","volume":"162","author":"Du","year":"2015","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/mp.2016.150","article-title":"MiR-137: an important player in neural development and neoplastic transformation","volume":"22","author":"Mahmoudi","year":"2017","journal-title":"Mol Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1158\/0008-5472.CAN-07-2912","article-title":"microRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines","volume":"68","author":"Bemis","year":"2008","journal-title":"Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1016\/j.biopha.2018.09.132","article-title":"Functions and mechanisms of microRNA-31 in human cancers","volume":"108","author":"Yu","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI39566","article-title":"microRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors","volume":"120","author":"Liu","year":"2010","journal-title":"J. Clin Invest"},{"key":"B60","doi-asserted-by":"publisher","first-page":"13742","DOI":"10.18632\/oncotarget.7328","article-title":"BAP1 suppresses lung cancer progression and is inhibited by miR-31","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"B61","doi-asserted-by":"publisher","first-page":"djv220","DOI":"10.1093\/jnci\/djv220","article-title":"Repression of esophageal neoplasia and inflammatory signaling by Anti-miR-31 delivery in vivo","volume":"107","author":"Taccioli","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41467-017-01059-5","article-title":"MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists","volume":"8","author":"Lv","year":"2017","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature08199","article-title":"Modulation of microRNA processing by p53","volume":"460","author":"Suzuki","year":"2009","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1073\/pnas.0808042106","article-title":"p53 represses c-Myc through induction of the tumor suppressor miR-145","volume":"106","author":"Sachdeva","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"B65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/ng.2007.30","article-title":"Widespread microRNA repression by Myc contributes to tumorigenesis","volume":"40","author":"Chang","year":"2008","journal-title":"Nat Genet"},{"key":"B66","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/cancers10040090","article-title":"Targeting the hippo pathway is a new potential therapeutic modality for malignant mesothelioma","volume":"10","author":"Sekido","year":"2018","journal-title":"Cancers"},{"key":"B67","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.cell.2013.12.043","article-title":"Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer","volume":"156","author":"Mori","year":"2014","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/cdd.2009.109","article-title":"p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC","volume":"17","author":"Christoffersen","year":"2010","journal-title":"Cell Death Differ"},{"key":"B69","doi-asserted-by":"publisher","first-page":"9762","DOI":"10.1158\/0008-5472.CAN-07-2462","article-title":"microRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells","volume":"67","author":"Sampson","year":"2007","journal-title":"Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1 function leads to EZH2-dependent transformation","volume":"21","author":"LaFave","year":"2015","journal-title":"Nat Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/1078-0432.CCR-11-0962","article-title":"Polycomb repressor complex-2 is a novel target for mesothelioma therapy","volume":"18","author":"Kemp","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"7095","DOI":"10.1007\/s13277-016-5017-y","article-title":"The role of microRNA-26a in human cancer progression and clinical application","volume":"37","author":"Chen","year":"2016","journal-title":"Tumour Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1182\/blood-2008-03-147645","article-title":"MYC stimulates EZH2 expression by repression of its negative regulator miR-26a","volume":"112","author":"Sander","year":"2008","journal-title":"Blood"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.18632\/oncotarget.622","article-title":"Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma","volume":"3","author":"Asangani","year":"2012","journal-title":"Oncotarget"},{"key":"B77","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab"},{"key":"B78","doi-asserted-by":"publisher","first-page":"15805","DOI":"10.1073\/pnas.0707628104","article-title":"microRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B","volume":"104","author":"Fabbri","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"B79","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejcb.2012.11.004","article-title":"The role of miRNA-29 family in cancer","volume":"92","author":"Wang","year":"2013","journal-title":"Eur J Cell Biol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nsmb.1533","article-title":"miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42","volume":"16","author":"Park","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s13277-015-3267-8","article-title":"Potential role of miR-100 in cancer diagnosis, prognosis, and therapy","volume":"36","author":"Qin","year":"2015","journal-title":"Tumour Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/eji.201747132","article-title":"The role of the miR-148\/-152 family in physiology and disease","volume":"47","author":"Friedrich","year":"2017","journal-title":"Eur J Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"R57","DOI":"10.1186\/gb-2014-15-4-r57","article-title":"Evidence for the biogenesis of more than 1,000 novel human microRNAs","volume":"15","author":"Friedlander","year":"2014","journal-title":"Genome Biol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"E1106","DOI":"10.1073\/pnas.1420955112","article-title":"Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs","volume":"112","author":"Londin","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1101\/gr.222067.117","article-title":"Toward the human cellular microRNAome","volume":"27","author":"McCall","year":"2017","journal-title":"Genome Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1165\/rcmb.2018-0204LE","article-title":"Discovery of previously undetected microRNAs in mesothelioma and their use as tissue-of-origin markers","volume":"61","author":"Martinez","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat Biotechnol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e3100","DOI":"10.1038\/cddis.2017.495","article-title":"Alternative mechanisms of miR-34a regulation in cancer","volume":"8","author":"Slabakova","year":"2017","journal-title":"Cell Death Dis"},{"key":"B89","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s41467-018-02989-4","article-title":"Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity","volume":"9","author":"Janas","year":"2018","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1158\/1535-7163.MCT-14-0209","article-title":"Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer","volume":"13","author":"Daige","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"B91","doi-asserted-by":"publisher","first-page":"4504","DOI":"10.1038\/s41467-018-06526-1","article-title":"6mer seed toxicity in tumor suppressive microRNAs","volume":"9","author":"Gao","year":"2018","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1021\/acs.accounts.9b00109","article-title":"Drug delivery with extracellular vesicles: from imagination to innovation","volume":"52","author":"de Jong","year":"2019","journal-title":"Acc Chem Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.013","article-title":"Biogenesis and function of extracellular vesicles in cancer","volume":"188","author":"Bebelman","year":"2018","journal-title":"Pharmacol Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1073\/pnas.0914843107","article-title":"Functional delivery of viral miRNAs via exosomes","volume":"107","author":"Pegtel","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ncb1800","article-title":"Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers","volume":"10","author":"Skog","year":"2008","journal-title":"Nat Cell Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat Cell Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.omtn.2019.04.027","article-title":"Emerging function and clinical values of exosomal microRNAs in cancer","volume":"16","author":"Wang","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B98","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nbt.1807","article-title":"Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes","volume":"29","author":"Alvarez-Erviti","year":"2011","journal-title":"Nat Biotechnol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/mt.2012.180","article-title":"Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells","volume":"21","author":"Ohno","year":"2013","journal-title":"Mol Ther"},{"key":"B100","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature22341","article-title":"Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer","volume":"546","author":"Kamerkar","year":"2017","journal-title":"Nature"},{"key":"B101","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/j.ymthe.2018.06.007","article-title":"Exosome-mediated small RNA delivery: a novel therapeutic approach for inflammatory lung responses","volume":"26","author":"Zhang","year":"2018","journal-title":"Mol Ther"},{"key":"B102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.canlet.2019.08.001","article-title":"Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication","volume":"463","author":"Monaco","year":"2019","journal-title":"Cancer Lett"},{"key":"B103","doi-asserted-by":"publisher","first-page":"eaat5690","DOI":"10.1126\/scitranslmed.aat5690","article-title":"Autologous tumor cell-derived microparticle-based targeted chemotherapy in lung cancer patients with malignant pleural effusion","volume":"11","author":"Guo","year":"2019","journal-title":"Sci Transl Med"},{"key":"B104","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1165\/rcmb.2003-0238OC","article-title":"Proteomic analysis of exosomes isolated from human malignant pleural effusions","volume":"31","author":"Bard","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"32643","DOI":"10.1038\/srep32643","article-title":"Secreted primary human malignant mesothelioma exosome signature reflects oncogenic cargo","volume":"6","author":"Greening","year":"2016","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/S0002-9440(10)63739-X","article-title":"Proteomic analysis of exosomes secreted by human mesothelioma cells","volume":"164","author":"Hegmans","year":"2004","journal-title":"Am J Pathol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00105\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T11:37:39Z","timestamp":1581075459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2020.00105\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":106,"alternative-id":["10.3389\/fonc.2020.00105"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2020.00105","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"article-number":"105"}}